244 related articles for article (PubMed ID: 21745515)
1. Role of NOD1/CARD4 and NOD2/CARD15 gene polymorphisms in cancer etiology.
Kutikhin AG
Hum Immunol; 2011 Oct; 72(10):955-68. PubMed ID: 21745515
[TBL] [Abstract][Full Text] [Related]
2. The role of NOD1/CARD4 and NOD2/CARD15 genetic variations in lung cancer risk.
Ozbayer C; Kurt H; Bayramoglu A; Gunes HV; Metintas M; Degirmenci İ; Oner KS
Inflamm Res; 2015 Oct; 64(10):775-9. PubMed ID: 26238283
[TBL] [Abstract][Full Text] [Related]
3. Influence of polymorphisms in the NOD1/CARD4 and NOD2/CARD15 genes on the clinical outcome of Helicobacter pylori infection.
Rosenstiel P; Hellmig S; Hampe J; Ott S; Till A; Fischbach W; Sahly H; Lucius R; Fölsch UR; Philpott D; Schreiber S
Cell Microbiol; 2006 Jul; 8(7):1188-98. PubMed ID: 16819970
[TBL] [Abstract][Full Text] [Related]
4. Genetic variation in NOD1/CARD4 and NOD2/CARD15 immune sensors and risk of osteoporosis.
Soyocak A; Özgen M; Turgut Coşan D; Kurt H; Doğaner F; Armağan O; Değirmenci İ; Şahin Mutlu F
Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32578848
[TBL] [Abstract][Full Text] [Related]
5. Investigation of NOD1/CARD4 variation in inflammatory bowel disease using a haplotype-tagging strategy.
Van Limbergen J; Nimmo ER; Russell RK; Drummond HE; Smith L; Anderson NH; Davies G; Arnott ID; Wilson DC; Satsangi J
Hum Mol Genet; 2007 Sep; 16(18):2175-86. PubMed ID: 17613538
[TBL] [Abstract][Full Text] [Related]
6. NOD2/CARD15, NOD1/CARD4, and ICAM-1 gene polymorphisms in Turkish patients with inflammatory bowel disease.
Ozen SC; Dagli U; Kiliç MY; Törüner M; Celik Y; Ozkan M; Soykan I; Cetinkaya H; Ulker A; Ozden A; Bozdayi AM
J Gastroenterol; 2006 Apr; 41(4):304-10. PubMed ID: 16741608
[TBL] [Abstract][Full Text] [Related]
7. NOD1 gene E266K polymorphism is associated with disease susceptibility but not with disease phenotype or NOD2/CARD15 in Hungarian patients with Crohn's disease.
Molnar T; Hofner P; Nagy F; Lakatos PL; Fischer S; Lakatos L; Kovacs A; Altorjay I; Papp M; Palatka K; Demeter P; Tulassay Z; Nyari T; Miheller P; Papp J; Mandi Y; Lonovics J;
Dig Liver Dis; 2007 Dec; 39(12):1064-70. PubMed ID: 17964870
[TBL] [Abstract][Full Text] [Related]
8. Nod1 and Nod2 in innate immunity and human inflammatory disorders.
Le Bourhis L; Benko S; Girardin SE
Biochem Soc Trans; 2007 Dec; 35(Pt 6):1479-84. PubMed ID: 18031249
[TBL] [Abstract][Full Text] [Related]
9. Effects of genetic variations in the genes encoding NOD1 and NOD2 on type 2 diabetes mellitus and insulin resistance.
Ozbayer C; Kurt H; Kebapci MN; Gunes HV; Colak E; Degirmenci I
J Clin Pharm Ther; 2017 Feb; 42(1):98-102. PubMed ID: 27885704
[TBL] [Abstract][Full Text] [Related]
10. NOD2/CARD15 polymorphisms impair innate immunity and increase susceptibility to gastric cancer in an Italian population.
Angeletti S; Galluzzo S; Santini D; Ruzzo A; Vincenzi B; Ferraro E; Spoto C; Lorino G; Graziano N; Calvieri A; Magnani M; Graziano F; Pantano F; Tonini G; Dicuonzo G
Hum Immunol; 2009 Sep; 70(9):729-32. PubMed ID: 19397946
[TBL] [Abstract][Full Text] [Related]
11. Association of polymorphisms in TLR genes and in genes of the Toll-like receptor signaling pathway with cancer risk.
Kutikhin AG
Hum Immunol; 2011 Nov; 72(11):1095-116. PubMed ID: 21872627
[TBL] [Abstract][Full Text] [Related]
12. NOD1 and NOD2 receptors: integral members of the innate and adaptive immunity system.
Antosz H; Osiak M
Acta Biochim Pol; 2013; 60(3):351-60. PubMed ID: 23901396
[TBL] [Abstract][Full Text] [Related]
13. NOD2/CARD15 genotype, cardiovascular disease and cancer in 43,600 individuals from the general population.
Yazdanyar S; Nordestgaard BG
J Intern Med; 2010 Aug; 268(2):162-70. PubMed ID: 20412372
[TBL] [Abstract][Full Text] [Related]
14. A functional variant in the CARD4 gene and risk of premature coronary heart disease.
El Mokhtari NE; Ott SJ; Nebel A; Simon R; Schreiber S
Int J Immunogenet; 2006 Aug; 33(4):307-11. PubMed ID: 16893397
[TBL] [Abstract][Full Text] [Related]
15. Investigation of innate immunity genes CARD4, CARD8 and CARD15 as germline susceptibility factors for colorectal cancer.
Möckelmann N; von Schönfels W; Buch S; von Kampen O; Sipos B; Egberts JH; Rosenstiel P; Franke A; Brosch M; Hinz S; Röder C; Kalthoff H; Fölsch UR; Krawczak M; Schreiber S; Bröring CD; Tepel J; Schafmayer C; Hampe J
BMC Gastroenterol; 2009 Oct; 9():79. PubMed ID: 19843337
[TBL] [Abstract][Full Text] [Related]
16. Association between a complex insertion/deletion polymorphism in NOD1 (CARD4) and susceptibility to inflammatory bowel disease.
McGovern DP; Hysi P; Ahmad T; van Heel DA; Moffatt MF; Carey A; Cookson WO; Jewell DP
Hum Mol Genet; 2005 May; 14(10):1245-50. PubMed ID: 15790594
[TBL] [Abstract][Full Text] [Related]
17. Toll-like receptor (TLR) and nucleosome-binding oligomerization domain (NOD) gene polymorphisms and endometrial cancer risk.
Ashton KA; Proietto A; Otton G; Symonds I; McEvoy M; Attia J; Scott RJ
BMC Cancer; 2010 Jul; 10():382. PubMed ID: 20646321
[TBL] [Abstract][Full Text] [Related]
18. Contribution of the NOD1/CARD4 insertion/deletion polymorphism +32656 to inflammatory bowel disease in Northern Europe.
Van Limbergen J; Russell RK; Nimmo ER; Törkvist L; Lees CW; Drummond HE; Smith L; Anderson NH; Gillett PM; McGrogan P; Hassan K; Weaver LT; Bisset WM; Mahdi G; Arnott ID; Sjöqvist U; Lördal M; Farrington SM; Dunlop MG; Wilson DC; Satsangi J
Inflamm Bowel Dis; 2007 Jul; 13(7):882-9. PubMed ID: 17285593
[TBL] [Abstract][Full Text] [Related]
19. Intracellular NOD-like receptors in host defense and disease.
Kanneganti TD; Lamkanfi M; Núñez G
Immunity; 2007 Oct; 27(4):549-59. PubMed ID: 17967410
[TBL] [Abstract][Full Text] [Related]
20. Mutations in pattern recognition receptor genes modulate seroreactivity to microbial antigens in patients with inflammatory bowel disease.
Henckaerts L; Pierik M; Joossens M; Ferrante M; Rutgeerts P; Vermeire S
Gut; 2007 Nov; 56(11):1536-42. PubMed ID: 17595233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
